International Journal of Applied and Basic Medical Research

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 11  |  Issue : 3  |  Page : 139--142

To analyze the role of intravenous tranexamic acid in hip fracture surgeries in orthopedic trauma


Girish Sahni1, Monika Sood2, Deepak Girdhar1, Priya Sahni1, Ayush Kumar Jain1, Sanjeev Kumar1 
1 Department Of Orthopaedics, Government Medical College and Hospital, Patiala, Punjab, India
2 Department Of Microbiology, Government Medical College and Hospital, Patiala, Punjab, India

Correspondence Address:
Sanjeev Kumar
6c, Ambey Apartment, Near Sai Market, Patiala - 147 001, Punjab
India

Introduction: Hip fractures in orthopedic trauma cases are increasing. Majority of such patients undergoing surgery require blood transfusion of one or more units. Intravenous (I. V.) Tranexamic acid (TXA) may decrease loss of blood, decrease need of blood transfusion, and improve postoperative hemoglobin (Hb) along with lesser adverse effects. Risk of thromboembolic phenomena remains a concern. A study was done to analyze the role of I. V. TXA in hip fracture surgeries in trauma cases. Materials and Methods: Sixty patients were included in the study; in two groups (37 males and 23 females), Group A in which two doses of I. V. TXA 15 mg/kg were given and Group B in which two doses of I. V. placebo were given. Results: Total number of randomized hip arthroplasty cases was 22 (11 in Group A and 11 in Group B) whereas randomized osteosynthesis cases were 38 (19 in Group A and 19 in Group B). Mean preoperative Hb value in Group A was 10.8 gm% and in Group B was 10.7 gm% (P > 0.005. Mean postoperative Hb value in Group A was Hb 9.8 gm% and in Group B 9.5 gm% (difference of 3.061%). Mean duration of surgery in Group A was 64.2 min and in Group B was 66.3 min. Mean total blood loss (intraoperative and postoperative) in Group A was 384.6 ml and in Group B was 448.7 ml (14.29% less in Group A). A total of 14 patients in Group A (17 red blood cells [RBCs] units) and 17 patients (21 RBC units) in Group B required RBC transfusion. No major vascular event, severe bacterial infections, symptomatic deep vein thrombosis, pulmonary embolism, limb ischemia, acute coronary syndrome, or immediate postoperative mortality was noted in either group. Conclusion: I. V. TXA has the potential to decrease risk of blood transfusion, decrease total blood loss, and to maintain a higher postoperative Hb value with no significant adverse reactions. As the number of cases of hip fractures continues to increase along with increase in age, so the use of TXA in such cases may improve clinical outcomes, lessen number of inpatient days and hence decrease overall cost.


How to cite this article:
Sahni G, Sood M, Girdhar D, Sahni P, Jain AK, Kumar S. To analyze the role of intravenous tranexamic acid in hip fracture surgeries in orthopedic trauma.Int J App Basic Med Res 2021;11:139-142


How to cite this URL:
Sahni G, Sood M, Girdhar D, Sahni P, Jain AK, Kumar S. To analyze the role of intravenous tranexamic acid in hip fracture surgeries in orthopedic trauma. Int J App Basic Med Res [serial online] 2021 [cited 2021 Dec 1 ];11:139-142
Available from: https://www.ijabmr.org/article.asp?issn=2229-516X;year=2021;volume=11;issue=3;spage=139;epage=142;aulast=Sahni;type=0